Actively Recruiting
Multi-modal Adverse Events Prediction for Premature Coronary Heart Disease Trial: MAP-CHD Trial
Led by China National Center for Cardiovascular Diseases · Updated on 2025-06-04
5000
Participants Needed
1
Research Sites
117 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this observational cohort study is to establish a risk prediction model for adverse events in Chinese individuals under 45 years old with premature coronary artery disease. The main questions it aims to answer are: * What are the major risk factors for poor prognosis in Chinese patients with premature coronary artery disease? * What is the difference in the prognosis of patients with premature coronary heart disease with different phenotypes? Participants taking no mandatory intervention will be followed up for 2 year, with blood tests at 1 year and outpatient or telephone interviews at other timepoints.
CONDITIONS
Official Title
Multi-modal Adverse Events Prediction for Premature Coronary Heart Disease Trial: MAP-CHD Trial
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18-45 years
- Clinically confirmed coronary artery disease with 50% or greater narrowing in at least one major coronary artery or significant branch verified by coronary angiography
- For patients with acute coronary syndrome or percutaneous coronary intervention: clinically stable and meeting discharge criteria after treatment
- Voluntary participation with signed informed consent
You will not qualify if you...
- Heart transplant recipients
- Severe systemic diseases with life expectancy less than 1 year
- Previous participation in other drug or device clinical trials without completing primary endpoint observation
- Unable to comply with follow-up due to conditions like dementia or severe psychiatric disorders
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
FuWai Hospital
Beijing, China
Actively Recruiting
Research Team
J
Jingjing Xu
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here